US Drug Recall Register
Class II · Moderate risk Completed Initiated Jul 2, 2019 (7 years ago)

Perrigo Neo-Polycin neomycin and polymixin B sulfates and…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Perrigo Neo-Polycin neomycin and polymixin B sulfates and bacitracin zinc Ophthalmic Ointment Net Wt. 3.5 g, Rx only, Manufactured for Perrigo Minneapolis, MN 55427 NDC 0574-4250-35

Recalling firm
Altaire Pharmaceuticals, Inc.
NDC code
0574-4250-35
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0353-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Zinc recalls

See all
Class II · Moderate risk Ongoing

Rohto Cooling Eye Drops ALL-IN-ONE

Reason Lack of Assurance of Sterility

Rohto-Mentholatum (Vietnam) Co., Ltd. NDC 10742-8146-1 D-0715-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0642-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0641-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0637-2026
Class II · Moderate risk Ongoing

Med Pride

Reason CGMP Deviations; deficiencies observed during FDA inspection

Dabur India Limited D-0636-2026